TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16850247

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel plus trastuzumab (4 mg/kg loading dose, then weekly 2 mg/kg)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Weekly paclitaxel alone (80 mg/m2)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel plus trastuzumab
Number of subjects: 124
Study: 15165944

Group type: EXPERIMENTAL
Intervention: Antegrade glutamate and aspartate (15 mmol/L) enriched cold crystalloid cardioplegia
Number of subjects: 34

Group type: COMPARATOR
Intervention: Cold crystalloid cardioplegia by antegrade route
Number of subjects: 34
Study: 12161089

Group type: EXPERIMENTAL
Intervention: Community intervention aimed at multiple cancer prevention health behaviors
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Baseline and follow-up surveys on intervention dose
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Surveys conducted in three similar communities in another part of the state
Number of subjects: 20
Study: 9612600

Group type: EXPERIMENTAL
Intervention: Intrahepatic artery cisplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous doxorubicin and 5-FU
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous 131I-polyclonal antiferritin (added to either regimen)
Number of subjects: 0
Study: 7927192

Group type: EXPERIMENTAL
Intervention: Pyridostigmine (PD), 120 mg po
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo, 2 tablets po
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Hydrocortisone succinate infusion (100 mg bolus followed by 250 mg infusion)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saline infusion (2 ml bolus followed by 250 ml infusion)
Number of subjects: 5
Study: 2521027

Group type: EXPERIMENTAL
Intervention: Nicardipine (5 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (5 mL of nicardipine solvent)
Number of subjects: 20
Study: 30705602

Group type: EXPERIMENTAL
Intervention: S-8117 (controlled-release oxycodone)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study: 28951845

Group type: EXPERIMENTAL
Intervention: Acupotomy (twice per week for 2 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Manual acupuncture (thrice per week for 2 weeks)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Acupotomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Manual acupuncture
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Acupotomy and Manual acupuncture
Number of subjects: 50
Study: 25207592

Group type: EXPERIMENTAL
Intervention: Moderate physical activity
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sedentary behavior
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Grade III breast cancer
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Professional occupation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adherence to nutritional guidelines
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Excessive adiposity
Number of subjects: 60
Study: 23801867

Group type: EXPERIMENTAL
Intervention: Fast-track surgery (FTS)
Number of subjects: 119
Study: 21795442

Group type: EXPERIMENTAL
Intervention: High Carbohydrates (HC) breakfast
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High Fat (HF) breakfast
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low Carbohydrates (LC) breakfast
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low Fat (LF) breakfast
Number of subjects: 16
Study: 20462102

Group type: EXPERIMENTAL
Intervention: Clinical supervision
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 18198636

Group type: EXPERIMENTAL
Intervention: Panax quinquefolius saponin (PQS) given orally for 4 weeks
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine Western medicine treatment
Number of subjects: 84
Study: 15548587

Group type: EXPERIMENTAL
Intervention: Theobromine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12392870

Group type: EXPERIMENTAL
Intervention: Second BCG vaccination
Number of subjects: 242401

Group type: COMPARATOR
Intervention: Control group (no second BCG vaccination)
Number of subjects: 242401
Study: 9972550

Group type: EXPERIMENTAL
Intervention: Persuasive communication from a stigmatized source (Black in Experiment 1; homosexual in Experiment 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Persuasive communication from a nonstigmatized source (White in Experiment 1; heterosexual in Experiment 2)
Number of subjects: 0
Study: 7552649

Group type: EXPERIMENTAL
Intervention: Full-time, intensive 3-week multidisciplinary program, including active physical and ergonomic training and psychological pain management, followed by 1 day weekly for the subsequent 3 weeks
Number of subjects: 132

Group type: COMPARATOR
Intervention: Active physical training, twice a week for 6 weeks, for a total of 24h
Number of subjects: 132

Group type: COMPARATOR
Intervention: Psychological pain management combined with active physical training, twice a week for 6 weeks, also for a total of 24h
Number of subjects: 132
Study: 2197001

Group type: EXPERIMENTAL
Intervention: Unlimited clear fluids up to three hours before surgery
Number of subjects: 121

Group type: COMPARATOR
Intervention: Prolonged fast (mean fast 14 hr)
Number of subjects: 121
Study: 6975197

Group type: EXPERIMENTAL
Intervention: 1,25‐dihydroxycholecalciferol [1,25‐(OH)2D3] at 0.25 microgram/day for 4-12 months
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 24,25‐dihydroxycholecalciferol [24,25‐(OH)2D3] at 2 microgram/day for 4-12 months
Number of subjects: 10
Study: 30701661

Group type: EXPERIMENTAL
Intervention: Method of Levels (MOL) therapy
Number of subjects: 12
Study: 28002685

Group type: EXPERIMENTAL
Intervention: Blood-flow restriction (BFR) applied via pressure cuff inflated to 220 mm Hg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (CNTRL) without blood-flow restriction
Number of subjects: 6
Study: 24705947

Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indacaterol 300 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24244918

Group type: EXPERIMENTAL
Intervention: Clonidine 1 (patients without addiction)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Clonidine 2 (patients with opium addiction)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo 1 (patients without addiction)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo 2 (patients with opium addiction)
Number of subjects: 160
Study: 20634639

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment for 6 and 12 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Matched controls (no GH treatment)
Number of subjects: 30
Study: 19745176

Group type: EXPERIMENTAL
Intervention: Repinotan (intravenous infusion for 72 hours)
Number of subjects: 681

Group type: COMPARATOR
Intervention: Placebo (intravenous infusion for 72 hours)
Number of subjects: 681
Study: 17685990

Group type: EXPERIMENTAL
Intervention: Soup kitchen
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Welfare office
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Detoxification centre
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Homeless outreach team
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Family member
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Emergency room
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Healthcare site (medical condition)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Healthcare site (mental health condition)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Social service agency (medical condition)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Social service agency (mental health condition)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Healthcare site (alcohol treatment need)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Family or friends (alcohol abuse/dependence)
Number of subjects: 230
Study: 15563363

Group type: EXPERIMENTAL
Intervention: Multidisciplinary service model delivering medication review including GP education, patient home visits, pharmacist medication reviews, primary healthcare team conferences, GP implementation of action plans, and follow-up surgery visits.
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Multidisciplinary service model delivering medication review
Number of subjects: 400
Study: 11677934

Group type: EXPERIMENTAL
Intervention: Palliative stomach resection
Number of subjects: 285

Group type: COMPARATOR
Intervention: Nonresective procedure
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Palliative resection
Number of subjects: 285
Study: 9131883

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Guided mastery therapy
Number of subjects: 46
Study: 8201166

Group type: EXPERIMENTAL
Intervention: 1-day-old hydrogel lenses
Number of subjects: 18

Group type: COMPARATOR
Intervention: 2-weeks-old hydrogel lenses
Number of subjects: 18
Study: 2979271

Group type: EXPERIMENTAL
Intervention: Kreon (3.6 g/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30348188

Group type: EXPERIMENTAL
Intervention: Family-based home health education intervention administered by female community health volunteers (FCHVs) for 12 months
Number of subjects: 224

Group type: COMPARATOR
Intervention: Wait-list control group managing glycemic condition as usual for 12 months
Number of subjects: 224
Study: 26748079

Group type: EXPERIMENTAL
Intervention: Short-duration, high-intensity interval training (15.0 ± 3.5 min, 5 days/week for 12 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Traditional exercise (walking for 40.0 ± 5.0 min at 65% of age-predicted maximum heart rate, 5 days/week for 12 weeks)
Number of subjects: 18
Study: 25192156

Group type: EXPERIMENTAL
Intervention: Laser-sintered surface implants
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acid-etched surface implants
Number of subjects: 60
Study: 22910159

Group type: COMPARATOR
Intervention: Teaching by faculty members
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Teaching by senior residents
Number of subjects: 28
Study: 20060830

Group type: EXPERIMENTAL
Intervention: Ghrelin (3 microg/kg, intravenous infusion, twice daily for 10 days)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (saline, intravenous infusion, twice daily for 10 days)
Number of subjects: 21
Study: 18061206

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15862051

Group type: EXPERIMENTAL
Intervention: Caring Code intervention explained by clinical instructors and reminders provided weekly.
Number of subjects: 480

Group type: COMPARATOR
Intervention: Control group (no Caring Code intervention).
Number of subjects: 480
Study: 12503902

Group type: EXPERIMENTAL
Intervention: Disulfiram
Number of subjects: 106

Group type: COMPARATOR
Intervention: No medication
Number of subjects: 106
Study: 9792381

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) regimen
Number of subjects: 0
Study: 7705677

Group type: EXPERIMENTAL
Intervention: Radiotherapy and sizofiran
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Radiotherapy and sizofiran with 5-fluorouracil
Number of subjects: 312

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Sizofiran
Number of subjects: 312
Study: 2677271

Group type: EXPERIMENTAL
Intervention: Computerized reminder system for physicians
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Patient questionnaire and educational hand-out on preventive care
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both interventions used together
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 39
Study: 491473

Group type: EXPERIMENTAL
Intervention: Timolol ophthalmic solution
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pilocarpine
Number of subjects: 50
Study: 30913165

Group type: EXPERIMENTAL
Intervention: Culturally tailored pain coping skills training (CST) program, 11 telephone-based sessions over 3 months
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Culturally tailored pain coping skills training (CST) program
Number of subjects: 248

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 248
Study: 27604374

Group type: EXPERIMENTAL
Intervention: FC-assisted TUR with 5-ALA
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Single instillation of doxorubicin
Number of subjects: 525

Group type: COMPARATOR
Intervention: WL-TUR only
Number of subjects: 525

Group type: COMPARATOR
Intervention: FC-assisted TUR without instillation
Number of subjects: 525
Study: 25723356

Group type: EXPERIMENTAL
Intervention: Cranberry extract and juice beverage (CEJB)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Low-calorie cranberry juice cocktail (LCJC)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 59
Study: 23826245

Group type: EXPERIMENTAL
Intervention: Optimal LV pacing configurations
Number of subjects: 16

Group type: COMPARATOR
Intervention: Worst LV pacing configurations
Number of subjects: 16

Group type: COMPARATOR
Intervention: Default distal LV pacing configurations
Number of subjects: 16

Group type: COMPARATOR
Intervention: Comparison of optimal vs worst LV pacing configurations
Number of subjects: 16
Study: 20736244

Group type: EXPERIMENTAL
Intervention: CPB blood flow based on cardiac index (CI)
Number of subjects: 22

Group type: COMPARATOR
Intervention: CPB blood flow based on body surface area (BSA)
Number of subjects: 22
Study: 19538625

Group type: EXPERIMENTAL
Intervention: Behavioral sleep intervention
Number of subjects: 219

Group type: COMPARATOR
Intervention: Healthy eating control group
Number of subjects: 219
Study: 16432463

Group type: EXPERIMENTAL
Intervention: Carriers of at least one R241 allele
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soluble ICAM-1 levels above 10 ng/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: K469E polymorphism
Number of subjects: 0
Study: 14744737

Group type: EXPERIMENTAL
Intervention: Conventional care
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Self-care only
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Nothing
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Self-care
Number of subjects: 353
Study: 11606667

Group type: EXPERIMENTAL
Intervention: Galantamine (24-32 mg/day)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 386
Study: 9777760

Group type: EXPERIMENTAL
Intervention: Carbon dioxide resurfacing laser 1
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Carbon dioxide resurfacing laser 2
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Carbon dioxide resurfacing laser 3
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 16
Study: 8170654

Group type: EXPERIMENTAL
Intervention: Foam brush saturated with chlorhexidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Toothbrush
Number of subjects: 0
Study: 3678263

Group type: EXPERIMENTAL
Intervention: Amiodarone (200 mg day-1)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 62
Study: 29739665

Group type: EXPERIMENTAL
Intervention: Large diameter lenses
Number of subjects: 25
Study: 27891180

Group type: EXPERIMENTAL
Intervention: Forefoot cushioning (FC)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Metatarsal pad (MP)
Number of subjects: 23
Study: 24231437

Group type: EXPERIMENTAL
Intervention: Patient Specific Instrumentation (PSI)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard surgical instruments (STD)
Number of subjects: 36
Study: 24520744

Group type: EXPERIMENTAL
Intervention: Distal vein patch modification
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (other forms of modification)
Number of subjects: 60
Study: 21160018

Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff repair with autologous platelet-rich fibrin matrix (PRFM)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Arthroscopic rotator cuff repair without augmentation
Number of subjects: 88
Study: 19069461

Group type: EXPERIMENTAL
Intervention: alpha-lipoic acid (600 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mexidol (300 mg/day)
Number of subjects: 0
Study: 16596054

Group type: EXPERIMENTAL
Intervention: Active hyperthyroidism (group A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Controlled hyperthyroidism on medical therapy (group B)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 45
Study: 14555901

Group type: COMPARATOR
Intervention: ACUVUE 2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PureVision
Number of subjects: 20
Study: 10961056

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA) in patients without URI (M NO URI)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Uncuffed Orotracheal Tube (T) in patients without URI (T NO URI)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA) in patients with URI (M URI)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Uncuffed Orotracheal Tube (T) in patients with URI (T URI)
Number of subjects: 400
Study: 8648215

Group type: EXPERIMENTAL
Intervention: Sialylated gonococci
Number of subjects: 11

Group type: COMPARATOR
Intervention: Unsialylated gonococci
Number of subjects: 11
Study: 1442643

Group type: EXPERIMENTAL
Intervention: Formal hypnosis with different treatment strategies (groups one and two)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Not applicable (group three, no hypnosis)
Number of subjects: 32
Study: 3512396

Group type: EXPERIMENTAL
Intervention: Dopamine (0.1 microgram/kg/min)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31751012

Group type: EXPERIMENTAL
Intervention: Osimertinib (80 mg once daily)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Comparator EGFR-TKIs (gefitinib at 250 mg once daily or erlotinib at 150 mg once daily)
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Osimertinib
Number of subjects: 556

Group type: COMPARATOR
Intervention: Comparator EGFR-TKIs
Number of subjects: 556
Study: 29576358

Group type: EXPERIMENTAL
Intervention: PAS (400 mg PS & 400 mg PA per day)
Number of subjects: 40
Study: 27578478

Group type: EXPERIMENTAL
Intervention: Tiotropium 5 μg
Number of subjects: 3474

Group type: EXPERIMENTAL
Intervention: Tiotropium 2.5 μg
Number of subjects: 3474

Group type: COMPARATOR
Intervention: Placebo 5 μg
Number of subjects: 3474

Group type: COMPARATOR
Intervention: Placebo 2.5 μg
Number of subjects: 3474
Study: 24918372

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Nocturnal supplemental oxygen
Number of subjects: 281

Group type: COMPARATOR
Intervention: Control (education on sleep hygiene and healthy lifestyle)
Number of subjects: 281
Study: 21762937

Group type: EXPERIMENTAL
Intervention: CorCap cardiac support device
Number of subjects: 107

Group type: COMPARATOR
Intervention: Optimal medical therapy alone
Number of subjects: 107
Study: 20525984

Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard Echocardiography (Standard Echo)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Contrast Echocardiography (Contrast Echo)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Single-Photon Emission Computed Tomography (SPECT)
Number of subjects: 150
Study: 17956932

Group type: EXPERIMENTAL
Intervention: Nurse-led parent-training program (12 sessions of Webster-Stratton Incredible Years)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Psychologist-led parent-training program (12 sessions of Webster-Stratton Incredible Years)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Minimal intervention (companion book only)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Nurse-led treatment (after 7 sessions)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Nurse-led treatment (after 9 sessions)
Number of subjects: 117
Study: 17689171

Group type: EXPERIMENTAL
Intervention: Kneeling beside the manikin on the floor (F)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Standing beside the manikin on a Table 37 cm in height (L)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Standing beside the manikin on a Table 63 cm in height (H)
Number of subjects: 18
Study: 15466678

Group type: EXPERIMENTAL
Intervention: Pathways case management intervention
Number of subjects: 329

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 329
Study: 11722719

Group type: EXPERIMENTAL
Intervention: Galloy (palladium-free gallium-based alloy)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Permite C (high-copper amalgam)
Number of subjects: 10
Study: 9223882

Group type: COMPARATOR
Intervention: Isotonic beverage 250 ml or apple juice 250 ml (Control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Two slices of bread with isotonic beverage or apple juice (Breakfast group)
Number of subjects: 40
Study: 8260372

Group type: EXPERIMENTAL
Intervention: Sequential ifosfamide/carboplatin
Number of subjects: 152

Group type: COMPARATOR
Intervention: Single agent carboplatin
Number of subjects: 152
Study: 3314458

Group type: EXPERIMENTAL
Intervention: Diltiazem (90 mg twice daily)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Atenolol (50 mg once daily)
Number of subjects: 27
Study: 30697986

Group type: EXPERIMENTAL
Intervention: Oxycodone hydrochloride
Number of subjects: 0
Study: 27755654

Group type: EXPERIMENTAL
Intervention: Complicated Grief Treatment (CGT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Interpersonal Psychotherapy (Control)
Number of subjects: 69
Study: 24974864

Group type: COMPARATOR
Intervention: Diluted Formocresol (FC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Calcium Hydroxide (CH)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy (LLLT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Calcium Hydroxide preceded by Low Level Laser Therapy (LLLT + CH)
Number of subjects: 60
Study: 24067553

Group type: EXPERIMENTAL
Intervention: CYD-TDV (3 doses at 0, 6, and 12 months)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo (first and second injection) and tetanus/diphtheria/acellular pertussis vaccine (third injection)
Number of subjects: 600